Studying why chronic inflammatory skin diseases differ between patients over time
Observes patients with several chronic inflammatory skin diseases to find factors shaping their course.
Plain-language title generated from the registry record
Registry title: Determinants of Chronic Inflammatory Skin Disease Trajectories
Key facts
- Where
- Kiel, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 80 years old?
Source: NCT05928169, who can take part
Where in Germany
- Department of Dermatology and Allergy, University Hospital Schleswig-HolsteinKiel, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Schleswig-Holstein
- Trial code
- NCT05928169
- Record updated
- 28 August 2026
- Original description
Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.Read full original descriptionShow less
Determinants of Chronic Inflammatory Skin Disease Trajectories
Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.
Inclusion: dermatologist-diagnosed inflammatory skin disease; informed consent.
Exclusion: concurrent participation in a clinical trial; use of systemic immunosuppressive therapy or phototherapy during the last 4 weeks or receipt of biologics therapy (e.g. dupilumab, tralokinumab) within the last 3 months; treatment of the target skin areas with topical corticosteroids, calcineurin inhibitors or emollients 24 hours before sample collection; subject and/or the legal guardians are not able to give written informed consent; pregnant and breastfeeding women.